日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

First-in-human dosimetry and safety evaluation of (68)Ga-αMSH derivative for PET imaging of melanoma

首次对用于黑色素瘤PET成像的(68)Ga-αMSH衍生物进行人体剂量测定和安全性评估

Zolghadri, Samaneh; Bakhshi Kashi, Mohsen; Vahidfar, Nasim; Farzanefar, Saeed; Karimian, Arezou; Mohammadi Ashnani, Mohammad Hossein; Yousefnia, Hassan

An efficacious opportunity for diagnosis and treatment of cancers: Radiolabeled fibroblast activation protein (FAP) inhibitors

放射性标记的成纤维细胞活化蛋白(FAP)抑制剂为癌症的诊断和治疗提供了一个有效的契机

Vahidfar, Nasim; Aghanejad, Ayuob

Comparison of diagnostic performance of [(68)Ga]-Ga-FAPI-46 and [(18)F]-FDG PET/CT imaging for the detection of lesions and disease staging in patients with breast cancer

比较[(68)Ga]-Ga-FAPI-46和[(18)F]-FDG PET/CT成像在乳腺癌患者病灶检测和疾病分期中的诊断性能

Radmehr, Kiana; Farzanefar, Saeed; Abbasi, Mehrshad; Salehi, Yalda; Karamzade-Ziarati, Najme; Emami-Ardekani, Alireza; Manafi-Farid, Reyhaneh; Vahidfar, Nasim; Beiki, Davood

A Review of Nuclear Medicine Approaches in the Diagnosis and the Treatment of Gynecological Malignancies

核医学在妇科恶性肿瘤诊断和治疗中的应用综述

Vahidfar, Nasim; Farzanefar, Saeed; Ahmadzadehfar, Hojjat; Molloy, Eóin N; Eppard, Elisabeth

Diagnostic Value of Radiolabelled Somatostatin Analogues for Neuroendocrine Tumour Diagnosis: The Benefits and Drawbacks of [(64)Cu]Cu-DOTA-TOC

放射性标记生长抑素类似物在神经内分泌肿瘤诊断中的诊断价值:[(64)Cu]Cu-DOTA-TOC 的优势和不足

Vahidfar, Nasim; Farzanehfar, Saeed; Abbasi, Mehrshad; Mirzaei, Siroos; Delpassand, Ebrahim S; Abbaspour, Farzad; Salehi, Yalda; Biersack, Hans Jürgen; Ahmadzadehfar, Hojjat

Theranostic Advances in Breast Cancer in Nuclear Medicine

核医学在乳腺癌诊疗方面的进展

Vahidfar, Nasim; Aghanejad, Ayuob; Ahmadzadehfar, Hojjat; Farzanehfar, Saeed; Eppard, Elisabeth

Transfusion reaction in a case with the rare Bombay blood group

罕见孟买血型输血反应病例

Shahshahani, Hayedeh Javadzadeh; Vahidfar, Mohamad Reza; Khodaie, Seyed Ali